Literature DB >> 8547337

Determination of three-dimensional solution structure of waglerin I, a toxin from Trimeresurus wagleri, using 2D-NMR and molecular dynamics simulation.

L C Chuang1, H M Yu, C Chen, T H Huang, S H Wu, K T Wang.   

Abstract

The solution conformation of a synthetic snake venom toxin waglerin I, has been determined by using proton nuclear magnetic resonance spectroscopy. By a combination of various two-dimensional NMR techniques, the 1H-NMR spectrum of waglerin I was completely assigned. A set of 247 interproton distance restraints was derived from nuclear Overhauser enhancement (NOE) measurements. These NOE constraints, in addition to the 2 dihedral angle restraints (from coupling constant measurements) and 7 omega torsion angel restraints for prolines, formed the basis of three-dimensional structure determined by molecular dynamics techniques. The 19 structures that were obtained satisfy the experimental restraints, and display small deviation from idealized covalent geometry. Analysis of converged structures indicates that the toxin has no special secondary structure. In the solution structure of waglerin I, the central ring region is well defined but the N- and C-termini possesses more disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8547337     DOI: 10.1016/0167-4838(95)00181-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

Review 1.  End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease.

Authors:  Steven M Sine
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

2.  Azemiopsin from Azemiops feae viper venom, a novel polypeptide ligand of nicotinic acetylcholine receptor.

Authors:  Yuri N Utkin; Christoph Weise; Igor E Kasheverov; Tatyana V Andreeva; Elena V Kryukova; Maxim N Zhmak; Vladislav G Starkov; Ngoc Anh Hoang; Daniel Bertrand; Joachim Ramerstorfer; Werner Sieghart; Andrew J Thompson; Sarah C R Lummis; Victor I Tsetlin
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.